Company news
Hims & Hers Health, Inc. news in 2026
Hims & Hers Health, Inc.'s news releases, calls and decks from 2026, newest first.
Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
November 18, 2026
Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results
November 9, 2026
Dr. Andrew Huberman Joins Hims & Hers Board of Directors
November 9, 2026
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
November 6, 2026
Hims & Hers Benefits Adds Grüns, Medjet, Tonal, and Viome for Whole-Body Health and Support When You Need It Most
November 5, 2026
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
October 21, 2026
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
October 12, 2026
Hers Launches in Australia, Built to Care for the Whole Woman
October 12, 2026
Hims & Hers Names Jon Franklin as Chief Accounting Officer
October 7, 2026
Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
August 31, 2026
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
August 12, 2026
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
August 10, 2026
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience
August 6, 2026
Hims & Hers Responds to FTC Lawsuit
July 29, 2026
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
July 17, 2026
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
July 13, 2026
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
June 4, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
June 3, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
June 2, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
June 2, 2026
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
May 28, 2026
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
May 21, 2026
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
May 18, 2026
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
May 18, 2026
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
May 11, 2026
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
April 28, 2026
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
April 13, 2026
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
March 26, 2026
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
March 10, 2026
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
March 10, 2026
Hims & Hers Announces Strategic Shift for US Weight Loss Business
March 9, 2026
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
February 19, 2026
Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
February 5, 2026
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
February 5, 2026
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
February 4, 2026
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 2, 2026
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over
January 29, 2026
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees
January 28, 2026
Calls in 2026
Decks in 2026
- Q2 2026 Earnings Presentation
Earnings · 39 slides · Aug 10, 2026
- Q1 2026 Earnings Presentation
Earnings · 39 slides · May 11, 2026